Keystone Urology

Lancaster, Pennsylvania 17604

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Cancer, Urothelial Carcinoma Recurrent

Studies at this site

• A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors — Completed